Company Information

CIN
Status
Date of Incorporation
28 November 2005
State / ROC
/ ROC Hyderabad
Industry
Sub Category
Last Balance Sheet
Last Annual Meeting
Paid Up Capital
68,937,000
Authorised Capital
70,000,000

Patents

Novel Intermediates Of (E) Methyl 3 (((4 (N Methyl 2 (4 Methylpiperazin 1 Yl)acetamido)phenyl)amino)(Phenyl)methylene) 2 Oxo 2,3 Dihydro 1 H Pyrrolo[2,3 B] Pyridine 6 Carboxylate

1. A novel compound, (E)-methyl 3-benzylidene-2,3-dihydro-2-oxo-l H-pyrrolo[2,3- b]pyridine-6-carboxylate, of Formula I

A Process For The Preparation Of (1 Methyl 1 H 1,2,4 Triazol 3 Yl)methanol

The present invention relates to a process for the preparation of (l-methyl-lH-l,2,4-triazol-3-yl) methanol (Formula 1) from (E, Z)-N'-(l-amino-2-chloroethylidene)-N-methylformo hydrazide (Formula 2)

Novel Process For The Preparation Of (E) Methyl 3 (((4 (N Methyl 2 (4 Methylpiperazin 1 Yl) Acetamindo)phenyl)amino)(Phenyl)methylene) 2 Oxo 2,3 Dihydro 1 H Pyrrolo[2,3 B]Pyridine 6 Carboxylate

Soft Copy Attached in PDF

(4 (N Novel Process For The Preparation Of (E) Methyl 3 ((Methyl 2 (4 Methylpiperazin 1 Yl)acetamido)phenyl)amino)(Phenyl)methylene) 2 Oxo 2,3 Dihydro 1 H Pyrrolo[2,3 B]Pyridine 6 Carboxylate

The present invention relates to a novel process of (B)-mcihyl 3-(({4-(N-methvl-2-(4-• methylpiperazin- l-yl)acetamido)phenyl)amino)(phenyl)meihylene)-2-o.\o-2:3-dihydro* I H-pyrrolo[2.3-b]pyridine-6-carboxylate of Formula I. through novel intermediates

An Improved Process For The Preparation Of Mebeverine

ABSTRACT: The present invention relates to an improved process for the preparation of Mebeverine of Formula

Simplified, Cost Effective Industrial Process For The Key Intermediates Of Vonoprazan Fumarate

Soft Copy Attached in PDF.

Trademarks